Themis Medicare Limited

Themis Medicare Limited (THEMISMED) is a micro-cap Healthcare company valued at ₹981 crore operating in Pharmaceuticals on the NSE and BSE.

Recent price move

Themis Medicare Limited last traded at ₹100.3, sharply down 5.85% on the day.

Recent developments

On 2026-09-23, the company announced a dividend of ₹0.50 per share, ex-date. Promoter shares pledged increased to 43.39% of promoter holding as of 2026-06-30. Foreign institutional holding dropped to 0.01% in the quarter.

Financial performance

The company's business has deteriorated, with annual revenue falling 15.7% and net profit plunging 96.2%. The latest quarter saw a sharp turnaround, with net profit swinging from a loss of ₹14 crore to a profit of ₹25 crore, while revenue declined 11.3% year-on-year.

Valuation multiples

The stock trades at 835.8 times earnings, a premium to the Healthcare median of 32.0, 3.33 times book value. It yields 0.4%.

Things to watch

The company's net profit margin has narrowed 7.1 percentage points to 0.3%, and return on equity remains at 0.3%. The stock is 24.2% below its 52-week high, and profit has declined 72.9% over the past three years.

Where it stands

The company's financial performance has weakened significantly, with annual net profit dropping 96.2% and profit margins collapsing. The latest quarter showed a profit swing, but the stock remains far below its 52-week high. Promoter shares pledged now account for 43.39% of their holding.

Summarised by DocStoX's model on 2026-10-18 from company filings, exchange data and news. This is a factual summary, not a rating or a recommendation. Informational only, not investment advice. Consult a SEBI-registered adviser before investing.